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In July 2008, the report considering identification of
miRNA associated with regulation of APC protein
expression level was published. Two types of MIRNA;
miR135a and miR-135b, which are encoded by three
genes, were described. Those genes are located on chro-
mosomes 3, 12 and 1. miR135a and miR-135b interact
with sequences 3 `UTR of mRNA of gene APC on the
basis of incomplete complementarity and lead to its
degradation. The changes in the sequences encoding
miR135a and miR-135b may lead to a change in their
affinity to the 3 `UTR of mRNA of the gene APC and
enhancing its degradation. It can result in a reduced
number of functional APC protein. Also, changes in the
sequence 3 `UTR of mRNA can change the affinity of
the sites recognized by miRNA or induce new sites
recognized by the miRNA and thus will induce rapid
degradation of mRNA. Both these situations would pro-
vide a similar effect such as observed in case of the
mutations leading to premature termination of protein
translation. It could not be excluded that the mutations
in the 3 `UTR and miRNA can also modify the disease
course if co-occurring with mutations in the APC gene
coding sequence.
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